These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16013781)

  • 1. Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens.
    Han LL; Sloutsky A; Canales R; Naroditskaya V; Shin SS; Seung KJ; Timperi R; Becerra MC
    Int J Tuberc Lung Dis; 2005 Jul; 9(7):818-21. PubMed ID: 16013781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru.
    Timperi R; Han LL; Sloutsky A; Becerra MC; Nardell EA; Salazar JJ; Smith-Fawzi MC
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):175-80. PubMed ID: 15732737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Process of acquiring drug resistance: retrospective review of records of MDR TB].
    Yoshiyama T; Ito K; Ogata H; Mitarai S; Hoshino H; Okumura M; Aman K; Aono A; Wada M
    Kekkaku; 2004 Dec; 79(12):717-24. PubMed ID: 15782617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB.
    Rich ML; Socci AR; Mitnick CD; Nardell EA; Becerra MC; Bonilla C; Bayona J; Seung KJ; Furin J; Farmer PE; Mukherjee JS
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):290-6. PubMed ID: 16562709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
    Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
    Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients.
    van Rie A; Warren RM; Beyers N; Gie RP; Classen CN; Richardson M; Sampson SL; Victor TC; van Helden PD
    J Infect Dis; 1999 Nov; 180(5):1608-15. PubMed ID: 10515823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of multidrug-resistant Mycobacterium tuberculosis isolates in Georgetown, Guyana.
    Menner N; Günther I; Orawa H; Roth A; Rambajan I; Wagner J; Hahn H; Persaud S; Ignatius R
    Trop Med Int Health; 2005 Dec; 10(12):1215-8. PubMed ID: 16359400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for drug resistant tuberculosis in southeast Turkey.
    Tanrikulu AC; Hosoglu S; Ozekinci T; Abakay A; Gurkan F
    Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
    Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance and IS6110-RFLP patterns of Mycobacterium tuberculosis in patients with recurrent tuberculosis in northern Thailand.
    Sukkasem S; Yanai H; Mahasirimongkol S; Yamada N; Rienthong D; Palittapongarnpim P; Khusmith S
    Microbiol Immunol; 2013 Jan; 57(1):21-9. PubMed ID: 23106595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistant tuberculosis in Denmark].
    Thomsen VO; Johansen IS; Bauer JO; Glismann SO; Lillebaek T
    Ugeskr Laeger; 2001 Mar; 163(13):1842-6. PubMed ID: 11293312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.